Диссертация (1174192), страница 18
Текст из файла (страница 18)
Baker, Jr., M.M. Holl //Bioconjug Chem. - 2009. - Vol. 20. - № 8. - P. 1503-1513.141. Kou L. The endocytosis and intracellular fate of nanomedicines: Implication forrational design / L. Kou, J. Sun, Y. Zhai, Z. He // Asian Journal of PharmaceuticalSciences. - 2013. - Vol. 8. - № 1. - P. 1-10.142. Xu S. Targeting receptor-mediated endocytotic pathways with nanoparticles:rationale and advances / S.
Xu, B.Z. Olenyuk, C.T. Okamoto, S.F. Hamm-Alvarez // AdvDrug Deliv Rev. - 2013. - Vol. 65. - № 1. - P. 121-138.143. Sahay G. Endocytosis of nanomedicines / G. Sahay, D.Y. Alakhova, A.V. Kabanov// J Control Release. - 2010. - Vol. 145. - № 3. - P. 182-195.144. Pelkmans L. Endocytosis via caveolae / L.
Pelkmans, A. Helenius // Traffic. - 2002.- Vol. 3. - № 5. - P. 311-320.145. Doherty G.J. Mechanisms of endocytosis / G.J. Doherty, H.T. McMahon // AnnuRev Biochem. - 2009. - Vol. 78. - P. 857-902.146. Alhakamy N.A. Noncovalently associated cell-penetrating peptides for genedelivery applications / N.A. Alhakamy, A.S. Nigatu, C.J.
Berkland, J.D. Ramsey // TherDeliv. - 2013. - Vol. 4. - № 6. - P. 741-757.147. Boisguerin P. Delivery of therapeutic oligonucleotides with cell penetrating peptides/ P. Boisguerin, S. Deshayes, M.J. Gait, L. O'Donovan, C. Godfrey, C.A. Betts, M.J.Wood, B. Lebleu // Adv Drug Deliv Rev. - 2015. - Vol. 87. - P.
52-67.148. Torchilin V.P. Cell penetrating peptide-modified pharmaceutical nanocarriers forintracellular drug and gene delivery / V.P. Torchilin // Biopolymers. - 2008. - Vol. 90. № 5. - P. 604-610.149. Yamano S. Long-term efficient gene delivery using polyethylenimine with modifiedTat peptide / S. Yamano, J. Dai, S. Hanatani, K. Haku, T. Yamanaka, M.
Ishioka, T.107Takayama, C. Yuvienco, S. Khapli, A.M. Moursi, J.K. Montclare // Biomaterials. - 2014.- Vol. 35. - № 5. - P. 1705-1715.150. Crombez L. A new potent secondary amphipathic cell-penetrating peptide for siRNAdelivery into mammalian cells / L. Crombez, G. Aldrian-Herrada, K. Konate, Q.N.Nguyen, G.K. McMaster, R.
Brasseur, F. Heitz, G. Divita // Mol Ther. - 2009. - Vol. 17.- № 1. - P. 95-103.151. Lam J.K. Effective endogenous gene silencing mediated by pH responsive peptidesproceeds via multiple pathways / J.K. Lam, W. Liang, Y. Lan, P. Chaudhuri, M.Y. Chow,K. Witt, L. Kudsiova, A.J. Mason // J Control Release. - 2012. - Vol. 158. - № 2. - P. 293303.152. Madani F. Mechanisms of cellular uptake of cell-penetrating peptides / F. Madani,S. Lindberg, U. Langel, S. Futaki, A. Graslund // J Biophys.
- 2011. - Vol. 2011. - P.414729.153. Zhang D. Cell-penetrating peptides as noninvasive transmembrane vectors for thedevelopment of novel multifunctional drug-delivery systems / D. Zhang, J. Wang, D. Xu// J Control Release. - 2016. - Vol. 229. - P. 130-139.154. Tang H. Receptor-Mediated Endocytosis of Nanoparticles: Roles of Shapes,Orientations, and Rotations of Nanoparticles / H. Tang, H. Zhang, H. Ye, Y.
Zheng // JPhys Chem B. - 2018. - Vol. 122. - № 1. - P. 171-180.155. Dawidczyk C.M. Nanomedicines for cancer therapy: state-of-the-art and limitationsto pre-clinical studies that hinder future developments / C.M. Dawidczyk, L.M. Russell,P.C. Searson // Front Chem. - 2014. - Vol. 2. - P. 69.156. Ediriwickrema A. Nanotherapy for Cancer: Targeting and Multifunctionality in theFuture of Cancer Therapies / A. Ediriwickrema, W.M. Saltzman // ACS Biomater SciEng. - 2015.
- Vol. 1. - № 2. - P. 64-78.157. Peer D. Nanocarriers as an emerging platform for cancer therapy / D. Peer, J.M.Karp, S. Hong, O.C. Farokhzad, R. Margalit, R. Langer // Nat Nanotechnol. - 2007. - Vol.2. - № 12. - P. 751-760.108158. Temsamani J. Vector-mediated drug delivery to the brain / J. Temsamani, C.Rousselle, A.R.
Rees, J.M. Scherrmann // Expert Opin Biol Ther. - 2001. - Vol. 1. - № 5.- P. 773-782.159. Bray N. Biologics: Transferrin' bispecific antibodies across the blood-brain barrier /N. Bray // Nat Rev Drug Discov. - 2015. - Vol. 14. - № 1. - P. 14-15.160. Alibolandi M.
In vitro and in vivo evaluation of therapy targeting epithelial-celladhesion-molecule aptamers for non-small cell lung cancer / M. Alibolandi, M.Ramezani, K. Abnous, F. Sadeghi, F. Atyabi, M. Asouri, A.A. Ahmadi, F. Hadizadeh //J Control Release. - 2015. - Vol. 209. - P. 88-100.161. Yang Z. Dual-Ligand Modified Polymer-Lipid Hybrid Nanoparticles for DocetaxelTargeting Delivery to Her2/neu Overexpressed Human Breast Cancer Cells / Z.
Yang,W. Tang, X. Luo, X. Zhang, C. Zhang, H. Li, D. Gao, H. Luo, Q. Jiang, J. Liu // J BiomedNanotechnol. - 2015. - Vol. 11. - № 8. - P. 1401-1417.162. Assaraf Y.G. The folate receptor as a rational therapeutic target for personalizedcancer treatment / Y.G. Assaraf, C.P. Leamon, J.A. Reddy // Drug Resist Updat. - 2014.- Vol. 17. - № 4-6. - P. 89-95.163.
Shan L. Multi-small molecule conjugations as new targeted delivery carriers fortumor therapy / L. Shan, M. Liu, C. Wu, L. Zhao, S. Li, L. Xu, W. Cao, G. Gao, Y. Gu //Int J Nanomedicine. - 2015. - Vol. 10. - P. 5571-5591.164. Goren D. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypassof multidrug-resistance efflux pump / D. Goren, A.T. Horowitz, D. Tzemach, M.Tarshish, S. Zalipsky, A. Gabizon // Clin Cancer Res. - 2000. - Vol. 6. - № 5.
- P. 19491957.165. Pan X. Tumour-selective drug delivery via folate receptor-targeted liposomes / X.Pan, R.J. Lee // Expert Opin Drug Deliv. - 2004. - Vol. 1. - № 1. - P. 7-17.166. Guo L. Targeted multidrug-resistance reversal in tumor based on PEG-PLL-PLGApolymer nano drug delivery system / L. Guo, H. Zhang, F. Wang, P. Liu, Y. Wang, G.Xia, R. Liu, X. Li, H. Yin, H. Jiang, B. Chen // Int J Nanomedicine. - 2015. - Vol.
10. P. 4535-4547.109167. Clark A.J. Increased brain uptake of targeted nanoparticles by adding an acidcleavable linkage between transferrin and the nanoparticle core / A.J. Clark, M.E. Davis// Proc Natl Acad Sci U S A. - 2015. - Vol. 112. - № 40. - P. 12486-12491.168. Liang M. H-ferritin-nanocaged doxorubicin nanoparticles specifically target and killtumors with a single-dose injection / M. Liang, K.
Fan, M. Zhou, D. Duan, J. Zheng, D.Yang, J. Feng, X. Yan // Proc Natl Acad Sci U S A. - 2014. - Vol. 111. - № 41. - P. 1490014905.169. Cao Y. Anti-tumor effect of RGD modified PTX loaded liposome on prostatic cancer/ Y. Cao, Y. Zhou, Q. Zhuang, L. Cui, X. Xu, R. Xu, X. He // Int J Clin Exp Med. - 2015.- Vol. 8. - № 8. - P. 12182-12191.170.
Perrot-Applanat M. VEGF isoforms / M. Perrot-Applanat // Cell Adh Migr. - 2012.- Vol. 6. - № 6. - P. 526-527.171. Rubio Demirovic A. Targeting human cancer cells with VEGF receptor-2-directedliposomes / A. Rubio Demirovic, C. Marty, S. Console, S.M. Zeisberger, C. Ruch, R.Jaussi, R.A. Schwendener, K. Ballmer-Hofer // Oncol Rep. - 2005. - Vol. 13. - № 2. - P.319-324.172. Yang L. Antitumor effect of endostatin overexpressed in C6 glioma cells isassociated with the down-regulation of VEGF / L. Yang, Z. Lin, J. Lin, S. Weng, Q.Huang, P. Zhang, J.
Fu // Int J Oncol. - 2011. - Vol. 38. - № 2. - P. 465-471.173. Shein S.A. Site-directed delivery of VEGF-targeted liposomes into intracranial C6glioma / S.A. Shein, N.V. Nukolova, A.A. Korchagina, T.O. Abakumova, Kiuznetsov, II,M.A. Abakumov, V.P. Baklaushev, O.I. Gurina, V.P. Chekhonin // Bull Exp Biol Med. 2015.
- Vol. 158. - № 3. - P. 371-376.174. Ferrara N. The biology of VEGF and its receptors / N. Ferrara, H.P. Gerber, J.LeCouter // Nat Med. - 2003. - Vol. 9. - № 6. - P. 669-676.175. Hendrix M.J. Remodeling of the microenvironment by aggressive melanoma tumorcells / M.J. Hendrix, E.A.
Seftor, D.A. Kirschmann, V. Quaranta, R.E. Seftor // Ann N YAcad Sci. - 2003. - Vol. 995. - P. 151-161.176. Towner R.A. Molecular magnetic resonance imaging approaches used to aid in theunderstanding of the tissue regeneration marker Met in vivo: implications for tissue110engineering / R.A. Towner, N. Smith, Y. Asano, S. Doblas, D. Saunders, R. SilasiMansat, F.
Lupu // Tissue Eng Part A. - 2010. - Vol. 16. - № 2. - P. 365-371.177. Mukherjee P. Potential therapeutic application of gold nanoparticles in B-chroniclymphocytic leukemia (BCLL): enhancing apoptosis / P. Mukherjee, R. Bhattacharya, N.Bone, Y.K. Lee, C.R. Patra, S. Wang, L. Lu, C. Secreto, P.C. Banerjee, M.J. Yaszemski,N.E. Kay, D. Mukhopadhyay // J Nanobiotechnology.
- 2007. - Vol. 5. - P. 4.178. Chen J. Using anti-VEGF McAb and magnetic nanoparticles as double-targetingvector for the radioimmunotherapy of liver cancer / J. Chen, H. Wu, D. Han, C. Xie //Cancer Lett. - 2006. - Vol. 231. - № 2. - P. 169-175.179. Gao H. Mechanics of receptor-mediated endocytosis / H. Gao, W. Shi, L.B.
Freund// Proc Natl Acad Sci U S A. - 2005. - Vol. 102. - № 27. - P. 9469-9474.180. Oh W.K. Cellular uptake, cytotoxicity, and innate immune response of silica-titaniahollow nanoparticles based on size and surface functionality / W.K. Oh, S. Kim, M. Choi,C. Kim, Y.S. Jeong, B.R. Cho, J.S. Hahn, J. Jang // ACS Nano. - 2010. - Vol. 4. - № 9. P.
5301-5313.181. Jiang W. Nanoparticle-mediated cellular response is size-dependent / W. Jiang, B.Y.Kim, J.T. Rutka, W.C. Chan // Nat Nanotechnol. - 2008. - Vol. 3. - № 3. - P. 145-150.182. Win K.Y. Effects of particle size and surface coating on cellular uptake of polymericnanoparticles for oral delivery of anticancer drugs / K.Y. Win, S.S. Feng // Biomaterials.- 2005. - Vol. 26. - № 15. - P. 2713-2722.183.
Osaki F. A quantum dot conjugated sugar ball and its cellular uptake. On the sizeeffects of endocytosis in the subviral region / F. Osaki, T. Kanamori, S. Sando, T. Sera,Y. Aoyama // J Am Chem Soc. - 2004. - Vol. 126. - № 21. - P. 6520-6521.184.
Liang S. Optimizing the Size of Micellar Nanoparticles for Efficient siRNA Delivery/ S. Liang, X.-Z. Yang, X.-J. Du, H.-X. Wang, H.-J. Li, W.-W. Liu, Y.-D. Yao, Y.-H.Zhu, Y.-C.W. Ma, Jun, Er-Wei // Adv. Funct. Mater. - 2015. - Vol. 25. - № 30. - P. 47784787.185. Zonghui Wei Y.R. Simulation and Experimental Assembly of DNA–GraftCopolymer Micelles with Controlled Morphology / Y.R. Zonghui Wei, John-Michael111Williford, Wei Qu, Kevin Huang, Shirley Ng, Hai-Quan Mao, and Erik Luijten // ACSBiomater. Sci.
Eng. - 2015. - Vol. 1. - № 6. - P. 448–455.186. Chithrani B.D. Elucidating the mechanism of cellular uptake and removal of proteincoated gold nanoparticles of different sizes and shapes / B.D. Chithrani, W.C. Chan //Nano Lett. - 2007. - Vol. 7. - № 6. - P. 1542-1550.187. Shi J. Effect of polyplex morphology on cellular uptake, intracellular trafficking,and transgene expression / J. Shi, J.L.
Choi, B. Chou, R.N. Johnson, J.G. Schellinger,S.H. Pun // ACS Nano. - 2013. - Vol. 7. - № 12. - P. 10612-10620.188. Gabrielson N.P. Efficient polyethylenimine-mediated gene delivery proceeds via acaveolar pathway in HeLa cells / N.P. Gabrielson, D.W. Pack // J Control Release. - 2009.- Vol. 136. - № 1. - P. 54-61.189. Chiarelli P.A. Bionanotechnology and the future of glioma / P.A.
Chiarelli, ZhangM., Ellenbogen R.G. // Surg Neurol Int. - 2015. - Vol. 6. - P. 45-58.190. Kuhn D.A. Different endocytotic uptake mechanisms for nanoparticles in epithelialcells and macrophages / D.A. Kuhn, D. Vanhecke, B. Michen, F. Blank, P. Gehr, A. PetriFink, B. Rothen-Rutishauser // Beilstein J Nanotechnol. - 2014. - Vol. 5. - P. 1625-1636.112.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
